Literature DB >> 1451254

Cross-bridge dynamics in human ventricular myocardium. Regulation of contractility in the failing heart.

R J Hajjar1, J K Gwathmey.   

Abstract

BACKGROUND: To investigate whether altered cross-bridge kinetics contribute to the contractile abnormalities observed in heart failure, we determined the mechanical properties of cardiac muscles from control and myopathic hearts. METHODS AND
RESULTS: Muscle fibers from normal (n = 5) and dilated cardiomyopathy (n = 6) hearts were obtained and chemically skinned with saponin. The muscles were then maximally activated at saturating calcium concentrations. Unloaded shortening velocities (V0) were determined in both groups. V0 in control was 0.72 +/- 0.09 Lmax/sec, whereas in myopathic muscles, V0 was 0.41 +/- 0.06 Lmax/sec at 22 degrees C. The muscles were also sinusoidally oscillated at frequencies ranging between 0.01 and 100 Hz. The dynamic stiffness of the muscles was calculated from the ratio of force response amplitude to length oscillation amplitude. At low frequencies (< 0.2 Hz) the stiffness was constant but was larger in myopathic muscles. In the range of 0.2-1 Hz, there was a drop in the magnitude of dynamic stiffness to approximately one quarter of the low-frequency baseline. This range reflects cross-bridge turnover kinetics. In control muscles, the frequency of minimum stiffness was 0.78 +/- 0.06 Hz, whereas it was 0.42 +/- 0.07 Hz in myopathic muscles. At higher frequencies, the dynamic stiffness increased and reached a plateau at 30 Hz. There were no differences in the plateau reached between control and myopathic muscles.
CONCLUSIONS: Because myopathic hearts have a markedly diminished energy reserve, the slowing of the cross-bridge cycling rate plays an important adaptational role in the observed contractility changes in human heart failure. Although the potential to generate maximal Ca(2+)-activated force is similar in normal and myopathic hearts, alterations in contractile protein composition could explain the diminished cross-bridge cycling rate in failing hearts.

Entities:  

Mesh:

Year:  1992        PMID: 1451254     DOI: 10.1161/01.cir.86.6.1819

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  20 in total

1.  Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation.

Authors:  M R Wolff; S H Buck; S W Stoker; M L Greaser; R M Mentzer
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 2.  Kinetics and energetics of the crossbridge cycle.

Authors:  David W Maughan
Journal:  Heart Fail Rev       Date:  2005-09       Impact factor: 4.214

3.  Impact of heart rate on cross-bridge cycling kinetics in failing and nonfailing human myocardium.

Authors:  Jae-Hoon Chung; Nima Milani-Nejad; Jonathan P Davis; Noah Weisleder; Bryan A Whitson; Peter J Mohler; Paul M L Janssen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-07-26       Impact factor: 4.733

4.  Altered tension cost in (TG(mREN-2)27) rats overexpressing the mouse renin gene.

Authors:  Carsten Zobel; Persephone Zavidou-Saroti; Birgit Bölck; Klara Brixius; Hannes Reuter; Konrad Frank; Holger Diedrichs; Jochen Müller-Ehmsen; Wilhelm Bloch; Robert H G Schwinger
Journal:  Eur J Appl Physiol       Date:  2006-10-25       Impact factor: 3.078

Review 5.  Myocardial phenotype changes in heart failure: cellular and subcellular adaptations and their functional significance.

Authors:  G Hasenfuss; H Just
Journal:  Br Heart J       Date:  1994-08

6.  Mg-ATPase and Ca+ activated myosin AtPase activity in ventricular myofibrils from non-failing and diseased human hearts--effects of calcium sensitizing agents MCI-154, DPI 201-106, and caffeine.

Authors:  Chukwuka Okafor; Ronglih Liao; Cynthia Perreault-Micale; Xiaoping Li; Toshiro Ito; Anna Stepanek; Angelia Doye; Pieter de Tombe; Judith K Gwathmey
Journal:  Mol Cell Biochem       Date:  2003-03       Impact factor: 3.396

Review 7.  In situ study of myofibrils, mitochondria and bound creatine kinases in experimental cardiomyopathies.

Authors:  V Veksler; R Ventura-Clapier
Journal:  Mol Cell Biochem       Date:  1994 Apr-May       Impact factor: 3.396

8.  Reduced length-dependent cross-bridge recruitment in skinned fiber preparations of human failing myocardium.

Authors:  Klara Brixius; Persephone Savidou-Zaroti; Wilhelm Bloch; Robert H G Schwinger
Journal:  Eur J Appl Physiol       Date:  2003-02-28       Impact factor: 3.078

9.  EMD 53998 acts as Ca(2+)-sensitizer and phosphodiesterase III-inhibitor in human myocardium.

Authors:  R Uhlmann; R H Schwinger; I Lues; E Erdmann
Journal:  Basic Res Cardiol       Date:  1995 Sep-Oct       Impact factor: 17.165

Review 10.  Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure.

Authors:  Mahesh P Gupta
Journal:  J Mol Cell Cardiol       Date:  2007-07-21       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.